The value of revascularization and adherence to therapy in the development of cardiovascular complications in long-term monitoring of patients with myocardial infarction of the right ventricle on the background of the Q-myocardial infarction of the left ventricular posterior wall

V.Y. Tseluyko, T.A. Lozova, V.P. Zheleznyy, O.S. Sasyuk

References 

1. Kovalenko VM, Kornatsky VМ. Diseases of the circulatory system as a medical and social and socio-political problem. Analytical and statistical textbook. Кyiv, 2014. 280 p. (in Ukr.).
2. Briffa T, Hickling S, Knuiman M. et al. Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005. BMJ. 2009;26:338-346.
3. Desai NR, Choudhry NK. Impediments to adherence to post myocardial infarction medications. Curr Cardiol Rep. 2013;15(1):322.
4. Din J, Janssen C, Robinson SD. et al. Non-adherence with clopidogrel after coronary stenting is associated with increased mortality and myocardial infarction. JACC. 2013;61:10-16.
5. Erne P, Schoenenberger AW, Burckhardt D. et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007;297:1985-1991.
6. Ginghina C, Bejan I, Ceck C. Modern risk stratification in coronary heart disease. J. MedLife. 2011;4(4):377-386.
7. Haji SA, Movahed A. Right ventricular infarction - diagnosis and treatment. Clin Cardiol. 2000;26(7):2023-2033.
8. Jensen CJ, Jochims M, Hunold P. et al. Right ventricular involvement in acute left ventricular myocardial infarction: prognostic implications of MRT findings. AJR. 2010;194:592-598.
9. Madsen JK, Nielsen TT, Grande P. et al. Revascularization compared to medical treatment in patients with silent vs. symptomatic residual ischemia after thrombolyzed myocardial infarction: the DANAMI study. Cardiology. 2007;108:243-251.
10. Montalescot G, Sechtem U, Achenbach S. et al. Task Force Members. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3004.
11. Shamir R, Eikelboom J. Madhu K. et al. Impact of right ventricular involvement on mortality a morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol. 2001;37:37-43.
12. Simpson SH, Eurich DT, Majumdar SR. et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;33:153-166.
13. Steg G, James S, Atar D. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012;33:2569-2619.
14. Steg PG, Thuaire C, Himbert D. et al. DECOPI(DEsobstruction COronaire en PostInfarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J. 2004;25:2187-2194.
15. Velazquez E, Lee K, Deja M. et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. New Engl. J. Med. 2011;364:1607-1616.
16. Windecker S, Kolh P, Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35:2541-2619.
17. Wong CK, White HD. Risk stratification of patients with right ventricular infarction: is there a need for a specific risk score? Eur Heart J. 2002;23:1642-1645.
18. Yusuf S, Flather M, Pogue J. et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without unitial ST elevation OASIS Registry Investigators. Lancet. 2000;152:507-514.